Dengue hemorhagic fever associated hemophagocytc lymphohistiocytosis in primigravida: A case report

Abstract

Rationale: Hemophagocytic lymphohistiocytosis (HLH) is a rare but severe complication of dengue virus infection, associated with high mortality. We report a case of a 9-week primigravida presenting with high grade fever spikes and a positive Dengue NS1 antigen. The patient exhibited worsening clinical parameters, including cytopenias.

Patient concerns: A primigravida at 9th week of gestation and this condition has limited diagnostic modalities and treatment options for HLH.

Diagnoses: HLH secondary to dengue hemorrhagic fever.

Outcomes: Intravenous steroids were initiated with monitoring of laboratory and clinical parameters. The patient recovered successfully after initiation of intravenous steroids. Oral steroids were subsequently tapered over an next eight-week period, leading to a successful recovery.

Lessons: This case is unique due to the interplay between dengue virus infection, HLH, and early pregnancy, characterized by overlapping clinical symptoms and limited treatment options. Prompt initiation of intravenous steroid therapy resulted in significant clinical improvement. This case highlights the critical importance of early identification and treatment of dengue associated HLH to reduce mortality. Furthermore, it underscores the urgent need for focused research on HLH in pregnant patients, particularly in low and middle income countries.

Keywords

Dengue haemorrhagic fever / Hemophagocytic lymphohistiocytosis / HLH / Pregnant female / Dexamethasone

References

[1] Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatr Int 2016; 58(9): 817-825.

[2] Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48(2): 124-131.

[3] National Center for Vector Borne Diseases Control. Dengue situation in India. [Online]. Available from: https://ncvbdc.mohfw.gov.in/index4.php?lang=1&level=0&linkid=431&lid=3715. [Accessed on 30 May 2024].

[4] Kan FK, Tan CC, Von Bahr Greenwood T, Khalid KE, Supramaniam P, Hed Myrberg I, et al. Dengue infection complicated by hemophagocytic lymphohistiocytosis: Experiences from 180 patients with severe dengue. Clin Infect Dis 2020; 70(11): 2247-2255.

[5] Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014; 66(9): 2613-2620.

[6] Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, et al. Reactive hemophagocytic syndrome in adults: A retrospective analysis of 162 patients. Am J Med 2014; 127(11): 1118-1125.

[7] Liu L, Cui Y, Zhou Q, Zhao H, Li X. Hemophagocytic lymphohistiocytosis during pregnancy: A review of the literature in epidemiology, pathogenesis, diagnosis and treatment. Orphanet J Rare Dis 2021; 16(1): 281.

[8] Song Y, Wang Z, Hao Z, Li L, Lu J, Kang H, et al. Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: A multicenter retrospective study. Orphanet J Rare Dis 2019; 14(1): 50.

[9] Teng CL, Hwang GY, Lee BJ, Wang RC, Chou MM. Pregnancy-induced hemophagocytic lymphohistiocytosis combined with autoimmune hemolytic anemia. J Chin Med Assoc 2009; 72(3): 156.